For example, METTL14 is identified as a tumor suppressor via manipulating the m6A-mediated processing of pri-miR126 [16], while METTL3 enhances m6A-modification of SOCS2 to promote the evolution of HCC [17]. This evidence concerns the gene METTL3 and hepatocellular carcinoma.